Cronos Group Stock News

CRON earnings call for the period ending December 31, 2021.

CRON earnings call for the period ending December 31, 2021.

Read more on https://www.fxstreet.com

Cronos Group Inc.'s (CRON) CEO Kurt Schmidt on Q3 2021 Results - Earnings Call Transcript

Cronos chain has grown by about 2.5x over the last three months, despite uncertain market conditions. The post Cronos Chain’s TLV Reaches $2.4B as Crypto.com Rebrands CRO appeared first on The Tokenist .

Ginkgo Bioworks is still a story stock and one that's expensive to buy into.

Cronos Group Inc. (NASDAQ: CRON ) (TSX:CRON) announced its 2021 third-quarter business results, revealing net revenue of $20.4 million, compared to $11.4 million in the same period of 2020. The increase year-over-year was primarily driven by continued growth in the adult-use market in Canada, increased sales in the Israeli medical cannabis market and increased sales in the U.S. segment. Q3 Financial Highlights Gross profit of $(0.7) million in Q3 2021 improved by $0.8 million from Q3 2020 . The increase in gross profit year-over-year was primarily driven by an increase in sales of cannabis extracts in the rest of world (ROW) segment, which carry a higher gross profit and gross margin than other product categories. Adjusted EBITDA of $(46.8) million in Q3 2021 decreased by $16.7 million from … Full story available on Benzinga.com

Cronos Group said Friday its third-quarter net income fell to $55.1 million, or 21 cents a share, from $95.2 million, or 18 cents a share, in the year-ago period. The latest quarter includes a $132.9 million gain on revaluation of derivative liabilities. Third-quarter net revenue at the cannabis company rose by $9 million to $20.4 million on growth in the Canadian adult use market, and increased cannabis sales in the U.S. and Israeli markets. Analysts expected a loss of 11 cents a share and sales of $23.9 million, according to a FactSet survey. Cronos said it expects to save $20 million to $25 million in 2022 as part of a strategic realignment initiative. The company also completed an audit committee evaluation and restated its second-quarter unaudited interim financial statements. Shares of Cronos Group rose 1.3% in premarket trades. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

Cronos Group press release (CRON): FQ3 GAAP EPS of $0.21 beats by $0.31.Revenue of $20.41M (+79.7% Y/Y) beats by $2.23M.Adjusted EBITDA of -$46.8 million in Q3 2021 decreased by…

Completed Audit Committee evaluation and restated Q2 2021 unaudited interim financial statements

Completed Audit Committee evaluation and restated Q2 2021 unaudited interim financial statements

Despite the name change, Cronos (CRO) has lost over 3% of its value within the last 24 hours and it is currently trading for $0.45.

Cronos Group CRON, -4.77% CRON, -4.59% said Friday its third-quarter net income fell to $55.1 million, or 21 cents a share, from $95.2 million, or 18 cents a share, in the year-ago period. The latest

TORONTO, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its 2021 Third Quarter Earnings Conference Call on Friday,